MetaCap

Harrow Insider Trades

NASDAQ: HROWHealth CareBiotechnology: Pharmaceutical PreparationsUSD

29.36-1.16 (-3.80%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
4 · $468.72K
Sales
7 · $9.63M
Shares bought / sold
15.50K / 234.82K
Net activity
Net selling $9.2 million

Harrow insider activity

Over the last 12 months, Harrow insiders reported 16 transactions on SEC Form 4: 4 open-market purchases and 7 sales. Insiders bought $468,720 and sold $9.6 million worth of stock, for net insider selling of $9.2 million. The largest seller was Opaleye Management Inc., with $9.2 million in reported sales.

The most recent filing shows Shojaei Amir (CHIEF SCIENTIFIC OFFICER) reporting a transaction in 11,250 shares at $35.96 on Aug 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put HROW's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

HROW insider transactions

Harrow insider transactions
DateInsiderTypeSharesValueFiling
Aug 14, 2026Shojaei AmirCHIEF SCIENTIFIC OFFICERSale11,250$450.00KForm 4
Aug 14, 2026Shojaei AmirCHIEF SCIENTIFIC OFFICEROption exercise11,250$404.55KForm 4
May 18, 2026SILVERNAIL LAUREN PDirectorBuy1,000$31.00KForm 4
May 18, 2026Graves Adrienne LDirectorBuy1,000$31.07KForm 4
May 14, 2026BAUM MARK LCHIEF EXECUTIVE OFFICERBuy10,000$302.00KForm 4
May 14, 2026BOLL ANDREW R.PRESIDENT AND CFOBuy3,500$104.65KForm 4
Mar 4, 2026Opaleye Management Inc.10% OwnerSale4,263$169.12KForm 4
Mar 4, 2026Opaleye Management Inc.10% OwnerSale134,000$5.32MForm 4
Mar 3, 2026Opaleye Management Inc.10% OwnerSale1,309$51.25KForm 4
Mar 3, 2026Opaleye Management Inc.10% OwnerSale59,000$2.31MForm 4
Feb 27, 2026Opaleye Management Inc.10% OwnerSale5,000$270.90KForm 4
Jan 6, 2026Opaleye Management Inc.10% OwnerSale20,000$1.07MForm 4
Dec 12, 2025BAUM MARK LCHIEF EXECUTIVE OFFICERTax withholding79,994$3.76MForm 4
Dec 12, 2025BAUM MARK LCHIEF EXECUTIVE OFFICEROption exercise180,000$711.00KForm 4
Dec 12, 2025BOLL ANDREW R.PRESIDENT AND CFOTax withholding26,665$1.25MForm 4
Dec 12, 2025BOLL ANDREW R.PRESIDENT AND CFOOption exercise60,000$237.00KForm 4
Jul 21, 2025BAUM MARK LCHIEF EXECUTIVE OFFICERTax withholding313,338$11.62MForm 4
Jul 21, 2025BAUM MARK LCHIEF EXECUTIVE OFFICEROption exercise600,000$4.72MForm 4
Jun 10, 2025Opaleye Management Inc.10% OwnerSale15,000$462.03KForm 4
Jun 9, 2025Opaleye Management Inc.10% OwnerSale15,204$461.79KForm 4
Jun 4, 2025Opaleye Management Inc.10% OwnerSale1,796$53.91KForm 4
Jun 3, 2025Opaleye Management Inc.10% OwnerSale3,000$90.12KForm 4
May 13, 2025Opaleye Management Inc.10% OwnerSale5,000$132.94KForm 4
May 12, 2025Opaleye Management Inc.10% OwnerSale10,000$258.96KForm 4
Apr 7, 2025BAUM MARK LChief Executive OfficerTax withholding300,363$6.94MForm 4
Apr 7, 2025SAHAREK JOHN P.CEO & President, ImprimisRxTax withholding109,475$2.53MForm 4
Apr 7, 2025BOLL ANDREW R.Chief Financial OfficerTax withholding136,745$3.16MForm 4
Apr 3, 2025BAUM MARK LChief Executive OfficerOption exercise762,300—Form 4
Apr 3, 2025SAHAREK JOHN P.CEO & President, ImprimisRxOption exercise277,200—Form 4
Apr 3, 2025BOLL ANDREW R.Chief Financial OfficerOption exercise346,500—Form 4
Mar 24, 2025Opaleye Management Inc.10% OwnerSale5,000$150.06KForm 4
Mar 18, 2025Opaleye Management Inc.10% OwnerSale5,000$148.20KForm 4
Mar 18, 2025Opaleye Management Inc.10% OwnerSale5,000$150.06KForm 4
Mar 18, 2025Opaleye Management Inc.10% OwnerSale5,000$148.20KForm 4
Feb 28, 2025Opaleye Management Inc.10% OwnerSale5,000$140.25KForm 4
Jan 22, 2025Opaleye Management Inc.10% OwnerSale20,000$711.81KForm 4
Sep 11, 2024SAHAREK JOHN P.CEO of ImprimisRxTax withholding45,140$1.87MForm 4
Sep 11, 2024SAHAREK JOHN P.CEO of ImprimisRxOption exercise90,000$663.30KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related